We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
-2.35%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$2.85B
AUM Growth
+$132M
Cap. Flow
+$223M
Cap. Flow %
7.84%
Top 10 Hldgs %
64.12%
Holding
111
New
25
Increased
23
Reduced
13
Closed
26

Top Buys

Rank Stock Value
1
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$172M
2
MET icon
MetLife
MET
+$21.3M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$13.5M
4
AIG icon
American International
AIG
+$13.4M
5
DG icon
Dollar General
DG
+$13M

Top Sells

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$32.6M
2
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
+$28.1M
3
IMGN
Immunogen Inc
IMGN
+$13.7M
4
BABA icon
Alibaba
BABA
+$12.8M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$8.93M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.65%
2 Healthcare 21.49%
3 Financials 2.87%
4 Communication Services 1.25%
5 Industrials 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLUE
26
DELISTED
bluebird bio
BLUE
$25.2M 0.89%
21,230
+1,930
+10% +$1.29M
IONS icon
27
Ionis Pharmaceuticals
IONS
$8.93B
$25M 0.88%
405,000
-50,000
-11% -$2.47M
BMY icon
28
CALL
Bristol-Myers Squibb
BMY
$129B
$23.6M 0.83%
400,000
-600,000
-60% -$33.8M
MET icon
29
MetLife
MET
$62.4B
$21.6M 0.76%
+448,800
New +$21.3M
KITE
30
DELISTED
Kite Pharma, Inc.
KITE
$20.2M 0.71%
350,000
+140,000
+67% +$5.89M
AIG icon
31
American International
AIG
$42.5B
$19.6M 0.69%
350,000
+250,000
+250% +$13.4M
APTV icon
32
Aptiv
APTV
$12.3B
$16.4M 0.57%
225,000
+25,000
+13% +$1.72M
GOOG icon
33
CALL
Alphabet (Google) Class C
GOOG
$4.11T
$15.8M 0.55%
601,647
+100,274
+20% +$2.69M
AMZN icon
34
CALL
Amazon
AMZN
$2.44T
$15.5M 0.54%
+1,000,000
New +$15.6M
MA icon
35
Mastercard
MA
$498B
$15.1M 0.53%
175,000
– –
ARRY
36
DELISTED
Array Biopharma Inc
ARRY
$14.2M 0.5%
3,000,000
– –
DG icon
37
Dollar General
DG
$28.4B
$14.1M 0.5%
+200,000
New +$13M
GM icon
38
General Motors
GM
$80.9B
$14M 0.49%
400,000
+100,000
+33% +$3.19M
LNKD
39
DELISTED
LinkedIn Corporation
LNKD
$13.8M 0.48%
+60,000
New +$13M
MS icon
40
Morgan Stanley
MS
$320B
$13.6M 0.48%
+350,000
New +$12.5M
C icon
41
CALL
Citigroup
C
$213B
$13.5M 0.47%
250,000
– –
GOOG icon
42
Alphabet (Google) Class C
GOOG
$4.11T
$13.2M 0.46%
+501,373
New +$13.5M
OXY icon
43
Occidental Petroleum
OXY
$55.7B
$12.1M 0.42%
+150,255
New +$12.5M
BRFS
44
CALL
DELISTED
BRF SA
BRFS
$11.7M 0.41%
+500,000
New +$12.2M
LNKD
45
CALL
DELISTED
LinkedIn Corporation
LNKD
$11.5M 0.4%
+50,000
New +$10.8M
ACOR
46
DELISTED
Acorda Therapeutics
ACOR
$10.2M 0.36%
2,083
– –
AGIO icon
47
Agios Pharmaceuticals
AGIO
$2.08B
$10.1M 0.35%
90,000
-100,000
-53% -$8.93M
GILD icon
48
CALL
Gilead Sciences
GILD
$165B
$9.43M 0.33%
+100,000
New +$10.3M
ARMK icon
49
Aramark
ARMK
$15B
$9.35M 0.33%
+415,500
New +$8.49M
BLUE
50
CALL
DELISTED
bluebird bio
BLUE
$9.17M 0.32%
+7,720
New +$5.16M
1
2
3 4 5

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q4 2014 Portfolio in Review

As of Q4 2014, Artal Group held 111 positions worth $2.85B, up 4.9% from $2.72B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Artal Group deployed $223M of net new capital in Q4 2014, opening 25 new positions and adding to 23 existing holdings. Its largest new stake was MetLife: 448,800 shares worth $21.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alibaba, an estimated $12.8M trimmed.

  • Artal Group's largest Q4 2014 buy was MetLife: 448,800 shares worth $21.6M.
  • Artal Group added most to Lexicon Pharmaceuticals in Q4 2014, an estimated $172M increase.
  • Artal Group's biggest Q4 2014 reduction was Alibaba, cutting an estimated $12.8M.
  • Artal Group fully exited AUXILIUM PHARAMCEUTICALS INC in Q4 2014, selling an estimated $32.6M.
  • Artal Group's ten largest holdings make up 64% of its $2.85B portfolio in Q4 2014.
  • Artal Group opened 25 new positions and closed 26 in Q4 2014.
  • Artal Group's portfolio value rose 4.9% quarter-over-quarter to $2.85B.

Based on Artal Group's 13F filing for Q4 2014, filed 13 Feb 2015.